Investigation of albumin properties in patients with chronic renal failure

Free Radical Research

Volumn 43, Issue 10, 2009, Pages 1008-1018

  Pieniazek, Anna ^a   Brzeszczynska, Joanna ^b   Kruszynska, Ilona ^a   Gwozdzinski, Krzysztof ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b HERIOT WATT UNIVERSITY   (United Kingdom)

Author keywords

Albumin; Chronic renal failure; Glycosylation; Haemodialysis; Oxidative stress

Indexed keywords

4,4' BIS(1 ANILINO 8 NAPHTALENESULFONIC ACID); 8 ANILINO 1 NAPHTHALENESULFONIC ACID; CARBONYL DERIVATIVE; FLUORESCEIN ISOTHIOCYANATE; FLUORESCENT DYE; GLYCOSYLATED PROTEIN; HUMAN SERUM ALBUMIN; HYDROPEROXIDE; MALEIMIDE; PLASMA PROTEIN; THIOL; UNCLASSIFIED DRUG;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONFORMATION; DIABETIC NEPHROPATHY; DISEASE EXACERBATION; GLOMERULONEPHRITIS; GLYCATION; HEMODIALYSIS; HUMAN; IN VIVO STUDY; KIDNEY POLYCYSTIC DISEASE; OXIDATION; OXIDATIVE STRESS; PLASMA VISCOSITY; PROTEIN FUNCTION; PROTEIN MODIFICATION;

ANTIOXIDANTS; CASE-CONTROL STUDIES; FEMALE; GLYCOSYLATION; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; RENAL DIALYSIS; SERUM ALBUMIN;

EID: 70450247117     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760903165003     Document Type: Article

References (54)

1. Himmelfarb J, Lazarus JM, Hakim R. Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis. Am J Kidney Dis 1990;17:271-276.
2. Klebanoff SJ. Oxygen metabolism and the toxic properties of phagocytes. Ann Intern Med 1980;93:480-489
3. Nguyen AT, Leyhias C, Zingraff J, Herbelin A, Noret C, Descamps-Latscha B. Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole blood. Kidney Int 1985;28:158-167.
4. Gwozdzinski K, Janicka M. Oxygen free radicals and red blood cell damage in acute renal failure. Biochem Soc Trans 1995;23:635S.
5. Gwozdzinski K, Janicka M, Brzeszczynska J, Luciak M. Changes in red blood cell membrane structure in patients with chronic renal failure. Acta Biochim Pol 1997;44:99-108.
6. Craddock PR, Fehr J, Dalmasso AP, Brigham KL, Jacob HS. Hemodialysis leucopenia: pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest 1977;59:879-888.
7. Morena M, Delbosc S, Dupuy AM, Canaud B, Cristol J. Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation. Hemodial Int 2005;9:37-46
8. Himmelfarb J, McMonagle E. Albumin is the major plasma protein target of oxidant stress in uremia. Kidney Int 2001;60:358-363.
9. Clemont G, Lecour S, Lahet JJ, Siohan P, Vergely C, Chevet D, Rifle G, Rochette L. Alteration in plasma antioxidant capacities in chronic renal failure and hemodialysis patients: a possible explanation for the increased cardiovascular risk in these patients. Cardiovasc Res 2000;74:619-623.
10. Mera K, Anraku M, Kitamura K, Nakajou K, Maruyama T, Otagiri M. The structure and function of oxidized albumin in hemodialysis patients: Its role in elevated oxidative stress via neutrophil burst. Biochem Biophys Res Commun 2005;9:1322-1328.
11. Balion CM, Draisey TF, Thibert RJ. Carbamylated hemoglobin and carbamylated plasma protein in hemodialyzed patients. Kidney Int 1998;53:488-495
12. Kraus LM, Kraus AP Jr. Carbamylation of amino acids and proteins in uremia. Kidney Int 2001;59:S102-S107.
13. Koshiishi I, Mamura Y, Imanari T Cyanate causes depletion of ascorbate in organisms. Biochim Biophys Acta 1997;1336: 566-574.
14. Finotti P, Pagetta A. Heparin-induced structural modifications and oxidative cleavage of human serum albumin in the absence and presence of glucose: implications for transcapil-lary leakage of albumin in hyperglycemia. Eur J Biochem 1997;247:1000-1008.
15. Dodge JT, Mitchell C, Hanahan DJ. The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch Biochem Biophys 1963;100:119-130.
16. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
17. Bagatolli LA, Kivatinitz SC, Aguilar F, Soto MA, Sotomayor P, Fidelio GD. Two distihguishable fluorescent modes of 1-anilino-8-naphthalenesulfonate bound to human albumin. J Fluorescence 1996;6:33-40
18. Haugland RP. Handbook of fluorescent probes and research products. 9th ed. Eugene, OR: Molecular Probes Inc; 2002. p 119-134.
19. Slavik J. Anilinonaphthalene sulfonate as probe of membrane composition and function. Biochim Biophys Acta 1982;694: 1-25
20. Ellman G. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-77.
21. Morse PD. Determining intracellular viscosity from rotational motion of spin labels. Methods Enzymol 1986;127:239-249.
22. Yamaguchi T, Takamura H, Matoba T, Terao J. HPLC method for evaluation of free radical-scavenging activity of foods by using 1,1-diphenyl-2- picrylhydrazyl. Biosci Biotech-nol Biochem 1998;62:1201-1204.
23. Kennedy I, Lyons TJ. Non-enzymatic glycosylation. Brit Med Bull 1998;45:174-190.
24. Gerardi GM, Usberti M, Martini G, Albertini A, Sugherini L, Pompella A, Di Lorenzo D. Plasma total antioxidant capacity in hemodialyzed patients and its relationship to other biomarkers of oxidative stress and lipid peroxidation. Clin Chem Lab Med 2002;40:104-110.
25. Trznadel K, Pawlicki Z, Kedziora J, Blaszczyk J, Buczynski A. Superoxide anion generation, erythrocytes superoxide dis-mutase activity and lipid peroxidation during hemoperfusion and hemodialysis in chronic eremic patients. Free Radic Biol Med 1990;8:429-432.
26. Gwozdzinski K, Slomiany A, Nishikawa H, Okazaki K, Slomiany BL. Gastric mucin hydrofobicity: effect of associated and covalently bound lipids, proteolysis and reduction. Biochem Int 1988;17:907-917.
27. McGrath LT, Douglas AF, McCean E, Brown JH, Doherty CC, Johnston GD, Archbold GPR. Oxidative stress and erythrocyte membrane fluidity in patients undergoing regular dialysis. Clin Chim Acta 1995;235:179-188.
28. Erdogan C, Unlucerci Y, Turkmen A, Kuku A, Cetin O, Bekpinar S. The evaluation of oxidative stress in patients with chronic renal failure. Clin Chim Acta 2002;322:157-161.
29. Morena M, Cristol JP, Senecal L, Leray-Moragues H, Krieter D, Canaud B. Oxidative stress in hemodialysis patients: Is NADPH oxidise complex the culprit? Kidney Int 2002;61: S109-S114.
30. Ziouzenkova O, Asatryan L, Tetta C, Wratten ML, Hwang J, Sevanian A. Oxidative stress during ex vivo hemodialysis of blood is decreased by a novel hemolipodialysis procedure utilizing antioxidants. Free Radic Biol Med 2002;33: 248-258.
31. Trepanier DJ, Thibert R, Draisey TF, Caines PS. Carbamy-lation of erythrocyte membrane proteins: an in vitro and in vivo study. Clin Biochem 1996;29:347-355. (Pubitemid 26249700)
32. Shaykh M, Pegoraro AA, Mo W, Arruda JAL, Dunea G, Siingh Ashok K. Carbamylated proteins active glomerular mesangial cells and stimulate collagen deposition. J Lab Clin Med 1999;133:302-308.
33. Chachou A, Randoux C, Millart H, Chanard J, Gillery Ph. Influence of in vivo hemoglobin carbamylation on HbA1C measurements by various methods. Clin Chem Lab Med 2000;38:321-326.
34. Hasuike Y, Nakanishi T, Maeda K, Tanaka T, Inoue T, Takamitsu Y. Carbamylated hemoglobin as a therapeutic marker in hemodialysis. Naphron 2002;91:228-234.
35. Pieniazek A, Gwozdzinski K. Carbamylation of proteins leads to alterations in the membrane structure of erythrocytes. Cell Mol Biol Lett 2003;8:127-131.
36. Hangland RP. The handbook. A guide to fluorescent probes and labelling technologies. Eugene, OR: Molecular Probes, Inc; 2005.
37. Anraku M, Kitamura K, Shinohara A, Adachi M, Suenga A, Maruyama T, Miyanaka K, Miyoshi T, Shiraishi N, Non-oguchi H, Otagiri M, Tomita K. Intravenous iron administration induces oxidation of serum albumin in hemodialysis patients. Kidney Int 2004;66:841-848. Erratum in Kidney Int 2004;66:1304.
38. Dursun E, Dursun B, Süleymanlar G, Ozben T Carbonyl stress in chronic renal failure: the effect of haemodialysis. Ann Clin Biochem 2005;42:64-66.
39. Levine RL, Williams JA, Stadtman ER, Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 1994;233:346-357.
40. Himmelfarb J, McMonagle E, McMenamin E. Plasma protein thiol oxidation and carbonyl formation in chronic renal failure. Kidney Int 2000;58:2571-2578.
41. Houbouyan L, Stoltz JF, Beauchet A, Prinseau J, Consoli N, Moulonguet-Doleris I, Baglin A, Goguel A. Erythrocyte aggregation before and after haemodialysis. Nephron 1995;70:267-268.
42. Hasler CR, Owen GR, Brunner W, Reinhart WH. Echinocy-tosis induced by haemodialysis. Naphrol Dial Transplant 1998;13:3132-3137.
43. Metry G, Spittle M, Rahmati S, Giller C, Giller A, Kaufman A, Schneditz D, Manno E, Brener Z, Boniece I, Ronco F, Ronco C, Levin NW. Online monitoring of cerebral hemodynamics during hemodialysis. Am J Kidney Dial 2002;40:996-1004.
44. Clermont G, Lecour S, Cabanne JF, Motte G, Guillando JC, Chevet D, Rochette L. Vitamin E-coated dialyser reduces oxidative stress in hemodialysis patients. Free Radic Biol Med 2001;31:233-241.
45. Galli F, Floridi AG, Floridi A, Buoncristiani U. Accumulation of vitamin E metabolites in the blood of renal failure patients. Clin Nutr 2004;32:205-212.
46. Usberti M, Gerardi GM, Gazzotti RM, Benedini S, Archetti S, Sugherini L, Valentini M, Tira P, Bufano G, Albartini A, Di Lorenzo D. Oxidative stress and cardiovascular disease in dialyzed patients. Nephron; Bologna, Italy. 2002;91:25-33.
47. Pieniazek A, Gwozdzinski K, Bujak S. Changes in reducing ability of blood plasma in chronic renal failure patients during hemodialysis. In: C Pasquier, editor, XI Biennial Meeting of the Society for Free Radical Research International. Monduzzi editore, International Proceeding Division; 2002. p 681-684.
48. Mayer B, Zitta S, Greilberger J, Holzen H, Reibnegger G, Hermetter A, Oettl K. Effect of hemodialysis on the antioxidative properties of serum. Biochim Biophys Acta 2003;1638:267-272.
49. Caimi G, Carollo C, Lo Presti R. Pathophysiological and clinical aspects of malnutrition in chronic renal failure. Nutr Res Rev 2005;18:89-97.
50. Mimic-Oka J, Simic T, Pljesa M, Stupar N, Turkovic S. Oxidtive modifications of plasma protein in different stages of chronic renal failure. Facta Univ Med Biol 2001;8:1-5.
51. Dursun E, Timur M, Dursun B, Suleymanlar G, Ozben T. Protein oxidation in type 2 diabetic patients on hemodialysis. J Diabetes Complicat 2005;19:142-146.
52. Selvaraj N, Bobby Z, Sridhar MG. Oxidative stress: does it play a role in the genesis of early glycated proteins? Med Hypotheses 2008;70:265-268.
53. Davies KJA. Protein damage and degradation by oxygen free radicals. II Modification of amino acids. J Biol Chem 1987;262:9902-9907.
54. Davies KJA. Protein damage and degradation by oxygen free radicals. IV Degradation of denatured proteins. J Biol Chem 1987;262:9914-9920.